DZ-1-artesunate conjugate induces mitochondria-mediated, reactive oxygen species-dependent apoptosis in colorectal cancer tumoroids
Frontiers in Pharmacology · 20.03.2026 · 17
DOI: 10.3389/fphar.2026.1743141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.03.2026. Verfasst von Badrinath Narayanasamy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cedars-Sinai Cancer Institute and Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We previously reported that the heptamethine cyanine dye–conjugated artesunate (DZ-1-ART) induces apoptosis in monolayer (2D) cell culture models. However, in 2D cultures, cells grow on flat, rigid plastic surfaces that fail to recapitulate the three-dimensional architecture of tumor tissues. This artificial environment alters cell polarity, morphology, and mechanical signaling, leading to non-physiological behavior. To overcome these limitations, we developed patient-derived tumoroids to assess the tumoricidal efficacy of the DZ-1-ART conjugate. In this study, tumoroids were established from fresh tissue samples of a malignant neoplasm of the sigmoid colon. The anticancer activity of DZ-1-ART was evaluated in these tumoroids. Propidium iodide staining confirmed DZ-1-ART–induced cytotoxicity, while TUNEL and immunoblotting assays demonstrated that this cytotoxicity was mediated by apoptosis. Furthermore, MitoTracker staining and near-infrared fluorescence indicated mitochondrial localization of DZ-1-ART. The JC-1 assay showed disruption of mitochondrial membrane potential following DZ-1-ART treatment. Additionally, deferoxamine and MitoTEMPO pretreatment revealed that DZ-1-ART induced mitochondria-mediated reactive oxygen species (ROS) generation in tumoroids. Collectively, these findings suggest that DZ-1-ART acts as a potent mitochondria-targeting anticancer agent with potential for precision therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cedars-Sinai Cancer Institute and Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
- Cedars-Sinai Cancer Institute and Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
- Cedars-Sinai Cancer Institute and Division of Hematology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
- Bio-Medical Institute of Technology, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
- Department of Microbiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
- Department of Urology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
Zitieren
APA
Narayanasamy, B., Zhang, Y., Gangi, A., Figlin, R., Sargsyan, K., Lee, H., Song, C., & Lee, Y. J. (2026). DZ-1-artesunate conjugate induces mitochondria-mediated, reactive oxygen species-dependent apoptosis in colorectal cancer tumoroids. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1743141
Vancouver
Narayanasamy B, Zhang Y, Gangi A, Figlin R, Sargsyan K, Lee H, et al. DZ-1-artesunate conjugate induces mitochondria-mediated, reactive oxygen species-dependent apoptosis in colorectal cancer tumoroids. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1743141
BibTeX
@article{Narayanasamy2026,
author = {Narayanasamy, Badrinath and Zhang, Yi and Gangi, Alexandra and Figlin, Robert and Sargsyan, Karine and Lee, Heuiran and Song, Cheryn and Lee, Yong J},
title = {DZ-1-artesunate conjugate induces mitochondria-mediated, reactive oxygen species-dependent apoptosis in colorectal cancer tumoroids},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1743141}
}
EUVIMED